Stay updated on Immunogenicity and Safety of NBP606 in Healthy Infants Clinical Trial

Sign up to get notified when there's something new on the Immunogenicity and Safety of NBP606 in Healthy Infants Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunogenicity and Safety of NBP606 in Healthy Infants Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The researcher record for the NBP606 infant immunogenicity and safety study is displayed, with its trial details, outcome measures, eligibility criteria, and administrative information.
    Difference
    42%
    Check dated 2026-11-13T10:42:00.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-30T10:42:56.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A site-wide banner announces an NIH transition notice stating that agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-23T10:20:02.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-16T14:11:26.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The 403 Forbidden message and its Home button are gone, but the clinical trial record area is blank.
    Difference
    0.5%
    Check dated 2026-10-02T15:53:17.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    Access to the study's Researcher view now returns a 403 Forbidden page, instead of displaying the trial details. This indicates an access/permissions issue that prevents viewing the core content and related navigation on the study record page.
    Difference
    17%
    Check dated 2026-09-25T16:31:08.000Z thumbnail image

Stay in the know with updates to Immunogenicity and Safety of NBP606 in Healthy Infants Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunogenicity and Safety of NBP606 in Healthy Infants Clinical Trial page.